Director of National Intelligence Tulsi Gabbard has formally justified her presence at an FBI search of a Georgia election facility, asserting her actions were within her legal authority to protect election integrity from foreign threats.
Analysts highlight Credo Technology Group (CRDO) as a core beneficiary of soaring cloud and AI data center spending, with revenue projected to nearly triple in FY2026 amid industry-wide capex surge.
Bank of America highlights Broadcom alongside Nvidia and AMD as a leading compute stock, fueled by robust AI infrastructure spending and compelling valuations, with Wells Fargo and Bernstein also raising targets.
In a move to rebalance bilateral trade, India has agreed to significant purchases of U.S. goods including petroleum, defense systems, and commercial aircraft under a newly announced agreement, a senior official confirmed.
Despite a recent share price dip and declining earnings per share, Harvey Norman Holdings (ASX:HVN) has generated a robust 82% total shareholder return since 2021, fueled by dividends and investor confidence in its long-term strategy.
Asian equities and gold rebounded sharply on Tuesday, recovering from a steep two-day sell-off. However, Bitcoin's steeper weekly losses highlight a growing performance gap, underscoring a shift in investor preference toward traditional markets that began in late 2024.
Iranian President Ebrahim Raisi has extended an olive branch to Washington, proposing renewed negotiations under what he terms "fair and equitable" conditions, signaling a potential shift in tone while core disputes remain unresolved.
Healthcare REIT National Health Investors (NHI) is aggressively expanding its senior housing operating portfolio, acquiring nine properties for $105.5 million while pursuing a pipeline of potential deals worth up to $359 million. This strategic shift raises questions about execution risks and financial leverage in a competitive sector.
While global small- and mid-cap stocks face headwinds, savvy investors are turning to Asia for overlooked opportunities. We examine three fundamentally strong companies with compelling growth trajectories.
After a stellar 2025, mobile advertising tech leader AppLovin faced a perfect storm of challenges last month, including renewed short-seller allegations, sector-wide valuation pressures, and market jitters over Google's new AI game-creation tool.
Chloe Cole, a prominent detransitioner advocate, sees a recent $2 million malpractice settlement in New York as a pivotal precedent, predicting a wave of similar lawsuits from young people who regret gender transition procedures.
Amidst record market levels, analysts highlight a select group of companies—from AI leaders to emerging fintech—with strong fundamentals and room for significant expansion.
Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.
A notable easing of US-Iran tensions has buoyed investor confidence across Gulf bourses, creating a favorable backdrop for stable, income-generating equities. We analyze three regional dividend stocks offering potential portfolio resilience amid shifting market dynamics.
Samsung Electronics unveils enhanced privacy controls for Galaxy devices and a special Olympic Edition of its foldable phone, aiming to bolster its brand in security and high-profile partnerships while its shares show significant long-term gains.
Werner Enterprises sees its fair value estimate raised significantly amid shifting analyst sentiment, driven by expectations of tighter truckload capacity and a potential freight market recovery.
Bio-Techne prepares to report quarterly earnings against a backdrop of declining revenue projections and mixed performances from life sciences peers.
Western wear retailer Boot Barn (NYSE: BOOT) is scheduled to release its fourth-quarter financial results after market close this Wednesday, with investors keenly watching for signs of sustained growth in a competitive apparel landscape.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
A sophisticated, high-conviction options trade by a large investor signals strong confidence in Edwards Lifesciences' fundamentals, with a potential breakout eyed for early 2026 tied to regulatory milestones and sustained growth in its mitral valve business.
